Adherence Monitoring Package (AMoPac) in patients suspected of non-response to antihypertensive treatment: perceived usefulness by general practitioners Article Swipe
Fine Dietrich
,
Andreas Zeller
,
Kurt E. Hersberger
,
Isabelle Arnet
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1136/bmjoq-2023-002451
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1136/bmjoq-2023-002451
Background Non-adherence to antihypertensive agents is common, mainly because of the low perceived burden of high blood pressure. General practitioners (GPs) are unable to predict whether patients are adhering to a recommended treatment. Knowledge about adherence might be of clinical interest in patients non-responding to antihypertensive treatment. Aim To assess the usefulness of an Adherence Monitoring Package (AMoPac) to identify non-adherence in patients non-responding to antihypertensive treatment. Methods AMoPac consists of (1) 4 weeks of electronic adherence monitoring, (2) pharmacist’s feedback on patient’s intake behaviour and (3) adherence metrics including clinical-pharmaceutical recommendations to the GP. AMoPac-HYP (‘ A dherence Mo nitoring Pac kage to identify non-adherence in ambulatory HYP ertensive patients’) is an observational study among GPs and ambulatory patients with hypertension in a real-world setting. The primary outcome was GPs’ perceived usefulness of AMoPac. Secondary outcomes were (1) frequency of medication problems and prescribing errors; (2) types of pharmacist’s’ recommendations; (3) acceptance of the recommendations by GPs; (4) medication adherence and (5) patients’ satisfaction. Outcomes are reported descriptively. Data were collected with questionnaires and electronic monitoring of medicine intake. Results Fifteen GPs and 15 patients with hypertension participated in the AMoPac-HYP Study. Patients were on average 62 years old, and mean blood pressure was 137/83 mmHg. All GPs rated AMoPac as useful. The most frequently mentioned use was excluding non-adherence in patients with hypertension (93%). Medication problems and prescribing errors were observed in 80% of the patients. The study pharmacist recommended adherence support (N=9 patients) and treatment optimisation (N=8 patients). The recommendations were accepted and implemented in 10 of 17 cases by the GP. Patients’ mean taking and timing adherence were 90% and 86%, respectively. Satisfaction with the study procedures among patients was high. Conclusion AMoPac was rated as useful for identifying and excluding non-adherence in patients with hypertension and was highly accepted among patients. Including adherence data in clinical decision-making could contribute to optimising patient care.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1136/bmjoq-2023-002451
- https://bmjopenquality.bmj.com/content/bmjqir/13/1/e002451.full.pdf
- OA Status
- gold
- References
- 19
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4390819850
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4390819850Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1136/bmjoq-2023-002451Digital Object Identifier
- Title
-
Adherence Monitoring Package (AMoPac) in patients suspected of non-response to antihypertensive treatment: perceived usefulness by general practitionersWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-01-01Full publication date if available
- Authors
-
Fine Dietrich, Andreas Zeller, Kurt E. Hersberger, Isabelle ArnetList of authors in order
- Landing page
-
https://doi.org/10.1136/bmjoq-2023-002451Publisher landing page
- PDF URL
-
https://bmjopenquality.bmj.com/content/bmjqir/13/1/e002451.full.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://bmjopenquality.bmj.com/content/bmjqir/13/1/e002451.full.pdfDirect OA link when available
- Concepts
-
Medicine, Observational study, Pharmacist, Ambulatory, Blood pressure, Ambulatory blood pressure, Clinical pharmacy, Medication adherence, Internal medicine, Emergency medicine, Physical therapy, Family medicine, PharmacyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
19Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4390819850 |
|---|---|
| doi | https://doi.org/10.1136/bmjoq-2023-002451 |
| ids.doi | https://doi.org/10.1136/bmjoq-2023-002451 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38216295 |
| ids.openalex | https://openalex.org/W4390819850 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D008875 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Middle Aged |
| mesh[2].qualifier_ui | Q000627 |
| mesh[2].descriptor_ui | D000959 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | therapeutic use |
| mesh[2].descriptor_name | Antihypertensive Agents |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D058005 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | General Practitioners |
| mesh[4].qualifier_ui | Q000188 |
| mesh[4].descriptor_ui | D006973 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | drug therapy |
| mesh[4].descriptor_name | Hypertension |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D055118 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Medication Adherence |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D017060 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Patient Satisfaction |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D006801 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Humans |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D008875 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Middle Aged |
| mesh[9].qualifier_ui | Q000627 |
| mesh[9].descriptor_ui | D000959 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | therapeutic use |
| mesh[9].descriptor_name | Antihypertensive Agents |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D058005 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | General Practitioners |
| mesh[11].qualifier_ui | Q000188 |
| mesh[11].descriptor_ui | D006973 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | drug therapy |
| mesh[11].descriptor_name | Hypertension |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D055118 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Medication Adherence |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D017060 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Patient Satisfaction |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D006801 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Humans |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D008875 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Middle Aged |
| mesh[16].qualifier_ui | Q000627 |
| mesh[16].descriptor_ui | D000959 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | therapeutic use |
| mesh[16].descriptor_name | Antihypertensive Agents |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D058005 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | General Practitioners |
| mesh[18].qualifier_ui | Q000188 |
| mesh[18].descriptor_ui | D006973 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | drug therapy |
| mesh[18].descriptor_name | Hypertension |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D055118 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Medication Adherence |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D017060 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Patient Satisfaction |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D006801 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Humans |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D008875 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Middle Aged |
| mesh[23].qualifier_ui | Q000627 |
| mesh[23].descriptor_ui | D000959 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | therapeutic use |
| mesh[23].descriptor_name | Antihypertensive Agents |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D058005 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | General Practitioners |
| mesh[25].qualifier_ui | Q000188 |
| mesh[25].descriptor_ui | D006973 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | drug therapy |
| mesh[25].descriptor_name | Hypertension |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D055118 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Medication Adherence |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D017060 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Patient Satisfaction |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D006801 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Humans |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D008875 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Middle Aged |
| mesh[30].qualifier_ui | Q000627 |
| mesh[30].descriptor_ui | D000959 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | therapeutic use |
| mesh[30].descriptor_name | Antihypertensive Agents |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D058005 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | General Practitioners |
| mesh[32].qualifier_ui | Q000188 |
| mesh[32].descriptor_ui | D006973 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | drug therapy |
| mesh[32].descriptor_name | Hypertension |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D055118 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Medication Adherence |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D017060 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Patient Satisfaction |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D006801 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Humans |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D008875 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Middle Aged |
| mesh[37].qualifier_ui | Q000627 |
| mesh[37].descriptor_ui | D000959 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | therapeutic use |
| mesh[37].descriptor_name | Antihypertensive Agents |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D058005 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | General Practitioners |
| mesh[39].qualifier_ui | Q000188 |
| mesh[39].descriptor_ui | D006973 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | drug therapy |
| mesh[39].descriptor_name | Hypertension |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D055118 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Medication Adherence |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D017060 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Patient Satisfaction |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D006801 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Humans |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D008875 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Middle Aged |
| mesh[44].qualifier_ui | Q000627 |
| mesh[44].descriptor_ui | D000959 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | therapeutic use |
| mesh[44].descriptor_name | Antihypertensive Agents |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D058005 |
| mesh[45].is_major_topic | True |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | General Practitioners |
| mesh[46].qualifier_ui | Q000188 |
| mesh[46].descriptor_ui | D006973 |
| mesh[46].is_major_topic | True |
| mesh[46].qualifier_name | drug therapy |
| mesh[46].descriptor_name | Hypertension |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D055118 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Medication Adherence |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D017060 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Patient Satisfaction |
| type | article |
| title | Adherence Monitoring Package (AMoPac) in patients suspected of non-response to antihypertensive treatment: perceived usefulness by general practitioners |
| biblio.issue | 1 |
| biblio.volume | 13 |
| biblio.last_page | e002451 |
| biblio.first_page | e002451 |
| topics[0].id | https://openalex.org/T11620 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9994999766349792 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2714 |
| topics[0].subfield.display_name | Family Practice |
| topics[0].display_name | Medication Adherence and Compliance |
| topics[1].id | https://openalex.org/T10144 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9970999956130981 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2705 |
| topics[1].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[1].display_name | Blood Pressure and Hypertension Studies |
| topics[2].id | https://openalex.org/T11792 |
| topics[2].field.id | https://openalex.org/fields/20 |
| topics[2].field.display_name | Economics, Econometrics and Finance |
| topics[2].score | 0.9433000087738037 |
| topics[2].domain.id | https://openalex.org/domains/2 |
| topics[2].domain.display_name | Social Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2002 |
| topics[2].subfield.display_name | Economics and Econometrics |
| topics[2].display_name | Pharmaceutical Economics and Policy |
| is_xpac | False |
| apc_list.value | 1500 |
| apc_list.currency | GBP |
| apc_list.value_usd | 1839 |
| apc_paid.value | 1500 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 1839 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9002803564071655 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C23131810 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7104729413986206 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q818574 |
| concepts[1].display_name | Observational study |
| concepts[2].id | https://openalex.org/C2779457091 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6275821924209595 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q105186 |
| concepts[2].display_name | Pharmacist |
| concepts[3].id | https://openalex.org/C35785553 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6218793392181396 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q756720 |
| concepts[3].display_name | Ambulatory |
| concepts[4].id | https://openalex.org/C84393581 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5694848895072937 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q82642 |
| concepts[4].display_name | Blood pressure |
| concepts[5].id | https://openalex.org/C149323552 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5322750806808472 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q3090739 |
| concepts[5].display_name | Ambulatory blood pressure |
| concepts[6].id | https://openalex.org/C10446079 |
| concepts[6].level | 3 |
| concepts[6].score | 0.45253050327301025 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q155491 |
| concepts[6].display_name | Clinical pharmacy |
| concepts[7].id | https://openalex.org/C3018553135 |
| concepts[7].level | 2 |
| concepts[7].score | 0.41258561611175537 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q67004728 |
| concepts[7].display_name | Medication adherence |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.39098483324050903 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C194828623 |
| concepts[9].level | 1 |
| concepts[9].score | 0.38889655470848083 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2861470 |
| concepts[9].display_name | Emergency medicine |
| concepts[10].id | https://openalex.org/C1862650 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3800450563430786 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q186005 |
| concepts[10].display_name | Physical therapy |
| concepts[11].id | https://openalex.org/C512399662 |
| concepts[11].level | 1 |
| concepts[11].score | 0.29792794585227966 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[11].display_name | Family medicine |
| concepts[12].id | https://openalex.org/C104863432 |
| concepts[12].level | 2 |
| concepts[12].score | 0.26429176330566406 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q614304 |
| concepts[12].display_name | Pharmacy |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9002803564071655 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/observational-study |
| keywords[1].score | 0.7104729413986206 |
| keywords[1].display_name | Observational study |
| keywords[2].id | https://openalex.org/keywords/pharmacist |
| keywords[2].score | 0.6275821924209595 |
| keywords[2].display_name | Pharmacist |
| keywords[3].id | https://openalex.org/keywords/ambulatory |
| keywords[3].score | 0.6218793392181396 |
| keywords[3].display_name | Ambulatory |
| keywords[4].id | https://openalex.org/keywords/blood-pressure |
| keywords[4].score | 0.5694848895072937 |
| keywords[4].display_name | Blood pressure |
| keywords[5].id | https://openalex.org/keywords/ambulatory-blood-pressure |
| keywords[5].score | 0.5322750806808472 |
| keywords[5].display_name | Ambulatory blood pressure |
| keywords[6].id | https://openalex.org/keywords/clinical-pharmacy |
| keywords[6].score | 0.45253050327301025 |
| keywords[6].display_name | Clinical pharmacy |
| keywords[7].id | https://openalex.org/keywords/medication-adherence |
| keywords[7].score | 0.41258561611175537 |
| keywords[7].display_name | Medication adherence |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.39098483324050903 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/emergency-medicine |
| keywords[9].score | 0.38889655470848083 |
| keywords[9].display_name | Emergency medicine |
| keywords[10].id | https://openalex.org/keywords/physical-therapy |
| keywords[10].score | 0.3800450563430786 |
| keywords[10].display_name | Physical therapy |
| keywords[11].id | https://openalex.org/keywords/family-medicine |
| keywords[11].score | 0.29792794585227966 |
| keywords[11].display_name | Family medicine |
| keywords[12].id | https://openalex.org/keywords/pharmacy |
| keywords[12].score | 0.26429176330566406 |
| keywords[12].display_name | Pharmacy |
| language | en |
| locations[0].id | doi:10.1136/bmjoq-2023-002451 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210206356 |
| locations[0].source.issn | 2399-6641 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2399-6641 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | BMJ Open Quality |
| locations[0].source.host_organization | https://openalex.org/P4310319945 |
| locations[0].source.host_organization_name | BMJ |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319945 |
| locations[0].source.host_organization_lineage_names | BMJ |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://bmjopenquality.bmj.com/content/bmjqir/13/1/e002451.full.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | BMJ Open Quality |
| locations[0].landing_page_url | https://doi.org/10.1136/bmjoq-2023-002451 |
| locations[1].id | pmid:38216295 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | BMJ open quality |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38216295 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10806575 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by-nc |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10806575/pdf/bmjoq-2023-002451.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | BMJ Open Qual |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10806575 |
| locations[3].id | pmh:oai:doaj.org/article:56e982251ea346a7aaa10b5efb162f16 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | BMJ Open Quality, Vol 13, Iss 1 (2024) |
| locations[3].landing_page_url | https://doaj.org/article/56e982251ea346a7aaa10b5efb162f16 |
| locations[4].id | pmh:oai:open-archive.highwire.org:bmjqir:13/1/e002451 |
| locations[4].is_oa | False |
| locations[4].source | |
| locations[4].license | |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | TEXT |
| locations[4].license_id | |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | |
| locations[4].landing_page_url | http://bmjopenquality.bmj.com/cgi/content/short/13/1/e002451 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5040937148 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-0672-6879 |
| authorships[0].author.display_name | Fine Dietrich |
| authorships[0].countries | CH |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1850255 |
| authorships[0].affiliations[0].raw_affiliation_string | Pharmaceutical Sciences, University of Basel, Basel, Switzerland |
| authorships[0].institutions[0].id | https://openalex.org/I1850255 |
| authorships[0].institutions[0].ror | https://ror.org/02s6k3f65 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I1850255 |
| authorships[0].institutions[0].country_code | CH |
| authorships[0].institutions[0].display_name | University of Basel |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Fine Dietrich |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Pharmaceutical Sciences, University of Basel, Basel, Switzerland |
| authorships[1].author.id | https://openalex.org/A5103031365 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-6170-8745 |
| authorships[1].author.display_name | Andreas Zeller |
| authorships[1].countries | CH |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1850255 |
| authorships[1].affiliations[0].raw_affiliation_string | Centre for Primary Health Care, University of Basel, Basel, Switzerland |
| authorships[1].institutions[0].id | https://openalex.org/I1850255 |
| authorships[1].institutions[0].ror | https://ror.org/02s6k3f65 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I1850255 |
| authorships[1].institutions[0].country_code | CH |
| authorships[1].institutions[0].display_name | University of Basel |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Andreas Zeller |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Centre for Primary Health Care, University of Basel, Basel, Switzerland |
| authorships[2].author.id | https://openalex.org/A5012672681 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-8678-697X |
| authorships[2].author.display_name | Kurt E. Hersberger |
| authorships[2].countries | CH |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1850255 |
| authorships[2].affiliations[0].raw_affiliation_string | Pharmaceutical Sciences, University of Basel, Basel, Switzerland |
| authorships[2].institutions[0].id | https://openalex.org/I1850255 |
| authorships[2].institutions[0].ror | https://ror.org/02s6k3f65 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I1850255 |
| authorships[2].institutions[0].country_code | CH |
| authorships[2].institutions[0].display_name | University of Basel |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Kurt E Hersberger |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Pharmaceutical Sciences, University of Basel, Basel, Switzerland |
| authorships[3].author.id | https://openalex.org/A5030223526 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-7591-4104 |
| authorships[3].author.display_name | Isabelle Arnet |
| authorships[3].countries | CH |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1850255 |
| authorships[3].affiliations[0].raw_affiliation_string | Pharmaceutical Sciences, University of Basel, Basel, Switzerland |
| authorships[3].institutions[0].id | https://openalex.org/I1850255 |
| authorships[3].institutions[0].ror | https://ror.org/02s6k3f65 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I1850255 |
| authorships[3].institutions[0].country_code | CH |
| authorships[3].institutions[0].display_name | University of Basel |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Isabelle Arnet |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Pharmaceutical Sciences, University of Basel, Basel, Switzerland |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://bmjopenquality.bmj.com/content/bmjqir/13/1/e002451.full.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Adherence Monitoring Package (AMoPac) in patients suspected of non-response to antihypertensive treatment: perceived usefulness by general practitioners |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11620 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9994999766349792 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2714 |
| primary_topic.subfield.display_name | Family Practice |
| primary_topic.display_name | Medication Adherence and Compliance |
| related_works | https://openalex.org/W2098338021, https://openalex.org/W2402520206, https://openalex.org/W3095771112, https://openalex.org/W2002125546, https://openalex.org/W2057467713, https://openalex.org/W4233169940, https://openalex.org/W2057135882, https://openalex.org/W4389244515, https://openalex.org/W2001072252, https://openalex.org/W2113853629 |
| cited_by_count | 0 |
| locations_count | 5 |
| best_oa_location.id | doi:10.1136/bmjoq-2023-002451 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210206356 |
| best_oa_location.source.issn | 2399-6641 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2399-6641 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | BMJ Open Quality |
| best_oa_location.source.host_organization | https://openalex.org/P4310319945 |
| best_oa_location.source.host_organization_name | BMJ |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319945 |
| best_oa_location.source.host_organization_lineage_names | BMJ |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://bmjopenquality.bmj.com/content/bmjqir/13/1/e002451.full.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | BMJ Open Quality |
| best_oa_location.landing_page_url | https://doi.org/10.1136/bmjoq-2023-002451 |
| primary_location.id | doi:10.1136/bmjoq-2023-002451 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210206356 |
| primary_location.source.issn | 2399-6641 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2399-6641 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | BMJ Open Quality |
| primary_location.source.host_organization | https://openalex.org/P4310319945 |
| primary_location.source.host_organization_name | BMJ |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319945 |
| primary_location.source.host_organization_lineage_names | BMJ |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://bmjopenquality.bmj.com/content/bmjqir/13/1/e002451.full.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | BMJ Open Quality |
| primary_location.landing_page_url | https://doi.org/10.1136/bmjoq-2023-002451 |
| publication_date | 2024-01-01 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2029896549, https://openalex.org/W1980533403, https://openalex.org/W2994857598, https://openalex.org/W2155441883, https://openalex.org/W2888589263, https://openalex.org/W2054559068, https://openalex.org/W2601416412, https://openalex.org/W6761690848, https://openalex.org/W4322505403, https://openalex.org/W3204538920, https://openalex.org/W2990199768, https://openalex.org/W4288843813, https://openalex.org/W2313754305, https://openalex.org/W2062339991, https://openalex.org/W2910781170, https://openalex.org/W2117648121, https://openalex.org/W3186700124, https://openalex.org/W2746562707, https://openalex.org/W2941690445 |
| referenced_works_count | 19 |
| abstract_inverted_index.4 | 72 |
| abstract_inverted_index.A | 97 |
| abstract_inverted_index.a | 30, 123 |
| abstract_inverted_index.10 | 258 |
| abstract_inverted_index.15 | 184 |
| abstract_inverted_index.17 | 260 |
| abstract_inverted_index.62 | 197 |
| abstract_inverted_index.Mo | 99 |
| abstract_inverted_index.To | 48 |
| abstract_inverted_index.an | 53, 112 |
| abstract_inverted_index.as | 211, 289 |
| abstract_inverted_index.be | 37 |
| abstract_inverted_index.by | 156, 262 |
| abstract_inverted_index.in | 41, 61, 106, 122, 189, 221, 233, 257, 296, 309 |
| abstract_inverted_index.is | 5, 111 |
| abstract_inverted_index.of | 9, 14, 38, 52, 70, 74, 133, 140, 148, 153, 177, 235, 259 |
| abstract_inverted_index.on | 81, 195 |
| abstract_inverted_index.to | 2, 23, 29, 44, 58, 64, 92, 103, 314 |
| abstract_inverted_index.(1) | 71, 138 |
| abstract_inverted_index.(2) | 78, 146 |
| abstract_inverted_index.(3) | 86, 151 |
| abstract_inverted_index.(4) | 158 |
| abstract_inverted_index.(5) | 162 |
| abstract_inverted_index.80% | 234 |
| abstract_inverted_index.90% | 272 |
| abstract_inverted_index.Aim | 47 |
| abstract_inverted_index.All | 207 |
| abstract_inverted_index.GP. | 94, 264 |
| abstract_inverted_index.GPs | 116, 182, 208 |
| abstract_inverted_index.HYP | 108 |
| abstract_inverted_index.Pac | 101 |
| abstract_inverted_index.The | 126, 213, 238, 251 |
| abstract_inverted_index.and | 85, 117, 143, 161, 174, 183, 200, 228, 246, 255, 268, 273, 293, 300 |
| abstract_inverted_index.are | 21, 27, 166 |
| abstract_inverted_index.for | 291 |
| abstract_inverted_index.low | 11 |
| abstract_inverted_index.the | 10, 50, 93, 154, 190, 236, 263, 278 |
| abstract_inverted_index.use | 217 |
| abstract_inverted_index.was | 129, 204, 218, 283, 287, 301 |
| abstract_inverted_index.(N=8 | 249 |
| abstract_inverted_index.(N=9 | 244 |
| abstract_inverted_index.(‘ | 96 |
| abstract_inverted_index.86%, | 274 |
| abstract_inverted_index.Data | 169 |
| abstract_inverted_index.GPs; | 157 |
| abstract_inverted_index.data | 308 |
| abstract_inverted_index.high | 15 |
| abstract_inverted_index.kage | 102 |
| abstract_inverted_index.mean | 201, 266 |
| abstract_inverted_index.most | 214 |
| abstract_inverted_index.old, | 199 |
| abstract_inverted_index.were | 137, 170, 194, 231, 253, 271 |
| abstract_inverted_index.with | 120, 172, 186, 223, 277, 298 |
| abstract_inverted_index.(GPs) | 20 |
| abstract_inverted_index.about | 34 |
| abstract_inverted_index.among | 115, 281, 304 |
| abstract_inverted_index.blood | 16, 202 |
| abstract_inverted_index.care. | 317 |
| abstract_inverted_index.cases | 261 |
| abstract_inverted_index.could | 312 |
| abstract_inverted_index.high. | 284 |
| abstract_inverted_index.might | 36 |
| abstract_inverted_index.mmHg. | 206 |
| abstract_inverted_index.rated | 209, 288 |
| abstract_inverted_index.study | 114, 239, 279 |
| abstract_inverted_index.types | 147 |
| abstract_inverted_index.weeks | 73 |
| abstract_inverted_index.years | 198 |
| abstract_inverted_index.(93%). | 225 |
| abstract_inverted_index.137/83 | 205 |
| abstract_inverted_index.AMoPac | 68, 210, 286 |
| abstract_inverted_index.GPs’ | 130 |
| abstract_inverted_index.Study. | 192 |
| abstract_inverted_index.agents | 4 |
| abstract_inverted_index.assess | 49 |
| abstract_inverted_index.burden | 13 |
| abstract_inverted_index.errors | 230 |
| abstract_inverted_index.highly | 302 |
| abstract_inverted_index.intake | 83 |
| abstract_inverted_index.mainly | 7 |
| abstract_inverted_index.taking | 267 |
| abstract_inverted_index.timing | 269 |
| abstract_inverted_index.unable | 22 |
| abstract_inverted_index.useful | 290 |
| abstract_inverted_index.AMoPac. | 134 |
| abstract_inverted_index.Fifteen | 181 |
| abstract_inverted_index.General | 18 |
| abstract_inverted_index.Methods | 67 |
| abstract_inverted_index.Package | 56 |
| abstract_inverted_index.Results | 180 |
| abstract_inverted_index.average | 196 |
| abstract_inverted_index.because | 8 |
| abstract_inverted_index.common, | 6 |
| abstract_inverted_index.errors; | 145 |
| abstract_inverted_index.intake. | 179 |
| abstract_inverted_index.metrics | 88 |
| abstract_inverted_index.outcome | 128 |
| abstract_inverted_index.patient | 316 |
| abstract_inverted_index.predict | 24 |
| abstract_inverted_index.primary | 127 |
| abstract_inverted_index.support | 243 |
| abstract_inverted_index.useful. | 212 |
| abstract_inverted_index.whether | 25 |
| abstract_inverted_index.(AMoPac) | 57 |
| abstract_inverted_index.Outcomes | 165 |
| abstract_inverted_index.Patients | 193 |
| abstract_inverted_index.accepted | 254, 303 |
| abstract_inverted_index.adhering | 28 |
| abstract_inverted_index.clinical | 39, 310 |
| abstract_inverted_index.consists | 69 |
| abstract_inverted_index.dherence | 98 |
| abstract_inverted_index.feedback | 80 |
| abstract_inverted_index.identify | 59, 104 |
| abstract_inverted_index.interest | 40 |
| abstract_inverted_index.medicine | 178 |
| abstract_inverted_index.nitoring | 100 |
| abstract_inverted_index.observed | 232 |
| abstract_inverted_index.outcomes | 136 |
| abstract_inverted_index.patients | 26, 42, 62, 119, 185, 222, 282, 297 |
| abstract_inverted_index.pressure | 203 |
| abstract_inverted_index.problems | 142, 227 |
| abstract_inverted_index.reported | 167 |
| abstract_inverted_index.setting. | 125 |
| abstract_inverted_index.Adherence | 54 |
| abstract_inverted_index.Including | 306 |
| abstract_inverted_index.Knowledge | 33 |
| abstract_inverted_index.Secondary | 135 |
| abstract_inverted_index.adherence | 35, 76, 87, 160, 242, 270, 307 |
| abstract_inverted_index.behaviour | 84 |
| abstract_inverted_index.collected | 171 |
| abstract_inverted_index.ertensive | 109 |
| abstract_inverted_index.excluding | 219, 294 |
| abstract_inverted_index.frequency | 139 |
| abstract_inverted_index.including | 89 |
| abstract_inverted_index.mentioned | 216 |
| abstract_inverted_index.patients) | 245 |
| abstract_inverted_index.patients. | 237, 305 |
| abstract_inverted_index.perceived | 12, 131 |
| abstract_inverted_index.pressure. | 17 |
| abstract_inverted_index.treatment | 247 |
| abstract_inverted_index.AMoPac-HYP | 95, 191 |
| abstract_inverted_index.Background | 0 |
| abstract_inverted_index.Conclusion | 285 |
| abstract_inverted_index.Medication | 226 |
| abstract_inverted_index.Monitoring | 55 |
| abstract_inverted_index.acceptance | 152 |
| abstract_inverted_index.ambulatory | 107, 118 |
| abstract_inverted_index.contribute | 313 |
| abstract_inverted_index.electronic | 75, 175 |
| abstract_inverted_index.frequently | 215 |
| abstract_inverted_index.medication | 141, 159 |
| abstract_inverted_index.monitoring | 176 |
| abstract_inverted_index.optimising | 315 |
| abstract_inverted_index.patients). | 250 |
| abstract_inverted_index.pharmacist | 240 |
| abstract_inverted_index.procedures | 280 |
| abstract_inverted_index.real-world | 124 |
| abstract_inverted_index.treatment. | 32, 46, 66 |
| abstract_inverted_index.usefulness | 51, 132 |
| abstract_inverted_index.Patients’ | 265 |
| abstract_inverted_index.identifying | 292 |
| abstract_inverted_index.implemented | 256 |
| abstract_inverted_index.monitoring, | 77 |
| abstract_inverted_index.patients’ | 163 |
| abstract_inverted_index.patient’s | 82 |
| abstract_inverted_index.prescribing | 144, 229 |
| abstract_inverted_index.recommended | 31, 241 |
| abstract_inverted_index.Satisfaction | 276 |
| abstract_inverted_index.hypertension | 121, 187, 224, 299 |
| abstract_inverted_index.optimisation | 248 |
| abstract_inverted_index.participated | 188 |
| abstract_inverted_index.patients’) | 110 |
| abstract_inverted_index.Non-adherence | 1 |
| abstract_inverted_index.non-adherence | 60, 105, 220, 295 |
| abstract_inverted_index.observational | 113 |
| abstract_inverted_index.practitioners | 19 |
| abstract_inverted_index.respectively. | 275 |
| abstract_inverted_index.satisfaction. | 164 |
| abstract_inverted_index.descriptively. | 168 |
| abstract_inverted_index.non-responding | 43, 63 |
| abstract_inverted_index.pharmacist’s | 79 |
| abstract_inverted_index.questionnaires | 173 |
| abstract_inverted_index.decision-making | 311 |
| abstract_inverted_index.recommendations | 91, 155, 252 |
| abstract_inverted_index.antihypertensive | 3, 45, 65 |
| abstract_inverted_index.recommendations; | 150 |
| abstract_inverted_index.pharmacist’s’ | 149 |
| abstract_inverted_index.clinical-pharmaceutical | 90 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5040937148 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| corresponding_institution_ids | https://openalex.org/I1850255 |
| citation_normalized_percentile.value | 0.00637798 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |